Literature DB >> 6151160

Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation.

O F Pomerleau, C S Pomerleau.   

Abstract

This paper examines findings on the neuroregulatory effects of nicotine in an effort to formulate a unified hypothesis that can explain the remarkable persistence of smoking behavior. Because nicotine alters the bioavailability of several behaviorally active neuroregulators, including acetylcholine, norepinephrine, dopamine, beta-endorphin, and vasopressin, we propose that nicotine is "used" by smokers to produce temporary improvements in performance or affect. Under this formulation, a potential large number of exteroceptive and interoceptive cues unrelated to the nicotine-dependence cycle may serve as discriminative stimuli for smoking, over and above smoking to terminate or avoid withdrawal. The rapid action of nicotine, and its diverse neuroregulatory effects, render it particularly effective as a "coping response" to the demands of daily living. Of special interest in this regard is a biphasic pattern of arousal/catecholaminergic activation followed by cholinergic blockade or beta-endorphin release. Apparently smokers can adjust nicotine intake to enhance these effects selectively, which may add considerably to the appeal of smoking.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151160     DOI: 10.1016/0149-7634(84)90007-1

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  65 in total

Review 1.  Nicotine dependence: a preventable risk factor for other diseases.

Authors:  C Cohen; J E Henningfield
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

2.  Euphoriant effects of nicotine in smokers.

Authors:  C S Pomerleau; O F Pomerleau
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences.

Authors:  N R Hoft; J A Stitzel; K E Hutchison; M A Ehringer
Journal:  Genes Brain Behav       Date:  2010-11-04       Impact factor: 3.449

4.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

5.  The acute effect of cigarette smoking on pattern visual evoked potentials.

Authors:  Ali H Durukan; Fatih C Gundogan; Uzeyir Erdem; Selim Kilic; Gungor Sobaci; M Zeki Bayraktar
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

Review 6.  Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General.

Authors:  J W Cullen; W Blot; J Henningfield; G Boyd; R Mecklenburg; M M Massey
Journal:  Public Health Rep       Date:  1986 Jul-Aug       Impact factor: 2.792

7.  Personality profile in type I alcoholism: long duration of alcohol intake and low serotonergic activity are predictive factors of anxiety proneness.

Authors:  K Berglund; C Fahlke; U Berggren; M Eriksson; J Balldin
Journal:  J Neural Transm (Vienna)       Date:  2006-02-06       Impact factor: 3.575

8.  Smokers unlikely to quit.

Authors:  N Owen; S L Brown
Journal:  J Behav Med       Date:  1991-12

9.  Depression and smoking in pregnancy in Scotland.

Authors:  C W Pritchard
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

Review 10.  Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model.

Authors:  Amanda R Mathew; Lee Hogarth; Adam M Leventhal; Jessica W Cook; Brian Hitsman
Journal:  Addiction       Date:  2016-10-26       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.